PT003 MDI Cardiovascular Safety Study

NCT01349803 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

237

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: PT005 MDI
DRUG: PT001 MDI
DRUG: PT003 MDI
DRUG: Formoterol Fumarate 12 μg (Foradil® Aerolizer®)

Sponsor

Pearl Therapeutics, Inc.